Late-onset Alzheimer's risk variants in memory decline, incident mild cognitive impairment, and Alzheimer's disease - Wikidata - wikimedia - TriplyDB

Late-onset Alzheimer's risk variants in memory decline, incident mild cognitive impairment, and Alzheimer's disease

Late-onset Alzheimer's risk variants in memory decline, incident mild cognitive impairment, and Alzheimer's disease

http://www.wikidata.org/entity/Q34718358

about

Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer's disease: the role, regulation and restoration of LRP1 Genetic variants in Alzheimer disease - molecular and brain network approaches APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice.Effect of APOE and CD33 on Cognitive Decline.Microglial malfunction: the third rail in the development of Alzheimer's disease.Alzheimer's Genetic Risk Intensifies Neurocognitive Slowing Associated with Diabetes in Non-Demented Older Adults Abca7 deletion does not affect adult neurogenesis in the mouse.ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.Plasma Clusterin and the CLU Gene rs11136000 Variant Are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients.Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer's Disease.Validating the role of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years Genome research in pre-dementia stages of Alzheimer's disease.Late Onset Alzheimer's Disease Risk Variants in Cognitive Decline: The PATH Through Life Study.Genetic and environmental factors associated with delirium severity in older adults with dementia.Genetic variants associated with risk of Alzheimer's disease contribute to cognitive change in midlife: The Atherosclerosis Risk in Communities Study.A Dopamine Receptor genetic variant enhances perceptual speed in cognitive healthy subjects Alzheimer's Disease rs11767557 Variant Regulates EPHA1 Gene Expression Specifically in Human Whole Blood.Association of glutathione S-transferases M1, P1 and T1 variations and risk of late-onset Alzheimer's disease.Shared effects of the clusterin gene on the default mode network among individuals at risk for Alzheimer's disease.ABCA7 and Pathogenic Pathways of Alzheimer's Disease.A Novel Association of Polymorphism in the ITGA4 Gene Encoding the VLA-4 α4 Subunit with Increased Risk of Alzheimer's Disease.

P2860

Q26800063-12F9C464-9783-4A30-A390-562F94825515 Q28596011-CBCF173F-3D87-40A1-94A9-AB6E5731D006 Q35337169-1FF6728E-A76F-4B62-90C5-04FFBB4FF9E6 Q35671748-3D9F440C-0D0B-4DBD-8C31-E17783E8A79F Q36348184-05E5A680-6DE6-463A-9C0A-8D86062F5D28 Q36350995-0A2D9D14-988D-4986-BBC4-CAD441984D94 Q36691233-D2BE5207-025F-4393-9694-84B9DFFB4C90 Q36741016-4EF88140-BAF9-4B2E-A1A5-AA06D6E01D7E Q37131933-45E386FC-5F35-4047-B806-38974E065592 Q37282153-AC37821F-19B8-470F-94F1-328E6D985C33 Q37680168-CB90E74F-7278-4046-A472-B601D35B801D Q38847374-A0559418-C546-4B5C-9A54-0828F419E042 Q38922835-7A99EF5A-E78B-4177-BB47-6D1710B8E6E2 Q39815953-6F13395D-C4B2-461A-8F57-35A64E133E61 Q40514964-13B5F257-D35E-4926-9DDE-34E5D3DF8643 Q42711931-F9E05305-A810-4997-8DC4-42C1DFF82092 Q47563696-4BBAC209-541F-4F8E-8FB6-51E9DEE74ADE Q47638524-9EA3ACBF-016D-4F3A-BB19-91E0076915CD Q47961634-9C4F25B7-2BDA-4E8B-954D-48EF07A4ED73 Q48104449-6C1A0397-F0D4-471A-990D-608306E7561A Q55259831-123BA763-D3E0-49AF-9E15-6DF7D759CDE0

P2860

Late-onset Alzheimer's risk variants in memory decline, incident mild cognitive impairment, and Alzheimer's disease

http://www.wikidata.org/entity/Q34718358

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Late-onset Alzheimer's risk va ...... rment, and Alzheimer's disease

@ast

Late-onset Alzheimer's risk va ...... rment, and Alzheimer's disease

@en

Late-onset Alzheimer's risk va ...... rment, and Alzheimer's disease

@nl

type

label

Late-onset Alzheimer's risk va ...... rment, and Alzheimer's disease

@ast

Late-onset Alzheimer's risk va ...... rment, and Alzheimer's disease

@en

Late-onset Alzheimer's risk va ...... rment, and Alzheimer's disease

@nl

prefLabel

Late-onset Alzheimer's risk va ...... rment, and Alzheimer's disease

@ast

Late-onset Alzheimer's risk va ...... rment, and Alzheimer's disease

@en

Late-onset Alzheimer's risk va ...... rment, and Alzheimer's disease

@nl

P1433

Q34718358-DBF274CA-530B-437A-AB33-A1A42FBA6D8A

P1476

Q34718358-ACD9157D-DE06-4288-8741-28279FD86405

P2093

Q34718358-101727A3-48C5-4994-B39A-7C71DAD5516F

Q34718358-10E9F7F6-3D43-4EFF-A610-CFC662119613

Q34718358-17CDE39F-77EB-475C-BC6A-92EF256C3752

Q34718358-26442C2B-4BC4-4EF1-B02C-03EEE13819C2

Q34718358-396D74FF-5FC5-4B17-BE62-C4D00B315594

Q34718358-3B71B478-9A60-4785-8F79-2197D68892E4

Q34718358-5CDC0387-FCD2-4BAD-B524-6EC1F5FF1AE3

Q34718358-74C7E366-DB67-4997-BFBE-2E8BD48018EA

Q34718358-777ACB63-3B59-411B-BBD5-62A331A9BB3A

Q34718358-A08229CF-FDCD-46BF-A37C-5C89429A281E

P2860

Q34718358-030073D3-5466-458A-B015-9B97B98C8F5F

Q34718358-0EC86CA3-E533-478F-AC0A-A462CF0ED1C2

Q34718358-1AA29B27-76A3-4CC4-B413-E72AEA7B372F

Q34718358-240BD1CF-6E43-47C5-AB19-1040D94D336C

Q34718358-2566FB9B-8E8D-468A-A352-AE062BA6F869

Q34718358-32ECB59B-96C2-4B6F-B879-DC0F1C472370

Q34718358-33F7422D-60B7-483E-885A-BC330D0F0211

Q34718358-3810DC8E-6F3F-4786-B166-631D075F5A03

Q34718358-6698D5BD-998D-4868-932E-3F54477B5074

Q34718358-6B9175AB-935A-428B-986A-EB41374A56AC

P304

Q34718358-AF7A4B8F-9F18-40E4-81CF-D2C4205457C0

P31

Q34718358-FA03CEA5-C7BC-4EED-B1BA-9EFFA9644424

P356

Q34718358-47F5EF50-DDD9-4C00-8E6C-4E94C422AD77

P433

Q34718358-5C373E73-7D18-4F33-AFC0-F6F0730B597B

P478

Q34718358-1CD5A4FD-85E9-4F53-B323-60A831CED7EF

P50

Q34718358-1182F489-E93D-431A-8368-5DDFDC9E3492

Q34718358-23C23E4D-3848-4798-A95E-D9BA3C925692

Q34718358-75E171C8-ED33-4F05-B3CA-92BE44063B23

Q34718358-C713FC13-023E-44E2-8E6C-72FFA2B2B5FC

P577

Q34718358-2642ACA3-76DF-4152-881B-6D7B94229937

P698

Q34718358-1E49ADEC-868D-45FE-B106-A9AD84282F4F

P921

Q34718358-B00D679D-A78F-4EC0-A6A2-CA0EEBA6675F

P932

Q34718358-5E10F2FF-11ED-4835-8990-96DDC030441E

P356

J.NEUROBIOLAGING.2014.07.042

P1433

Neurobiology of Aging

P1476

Late-onset Alzheimer's risk va ...... rment, and Alzheimer's disease

@en

P2093

Colleen S Thomas

http://www.w3.org/2001/XMLSchema#string

Gina D Bisceglio

http://www.w3.org/2001/XMLSchema#string

John A Lucas

http://www.w3.org/2001/XMLSchema#string

Julia E Crook

http://www.w3.org/2001/XMLSchema#string

Kimberly G Malphrus

http://www.w3.org/2001/XMLSchema#string

Li Ma

http://www.w3.org/2001/XMLSchema#string

Mariet Allen

http://www.w3.org/2001/XMLSchema#string

Mary M Machulda

http://www.w3.org/2001/XMLSchema#string

Neill R Graff-Radford

http://www.w3.org/2001/XMLSchema#string

Otto Pedraza

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

Clinical practice. Mild cognitive impairment.

Replication of CLU, CR1, and PICALM associations with alzheimer disease.

P304

60-67

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEUROBIOLAGING.2014.07.042

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

Nilüfer Ertekin-Taner

Ronald C. Petersen

Minerva M Carrasquillo

P577

2014-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25189118

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4268433

http://www.w3.org/2001/XMLSchema#string